Springboard Capital Asset Manager Profile - aVenture Research
Springboard Capital focuses on early-stage investments, particularly in the Series A and post-IPO equity rounds. The firm's investment strategy appears to target the healthcare and biotechnology sectors, with a particular emphasis on pharmaceutical and medical device companies.
Notable portfolio companies include Amulet Pharmaceuticals and Axogen, a leader in peripheral nerve repair solutions. Springboard Capital provides comprehensive investment management services, including portfolio management and financial planning, leveraging their expertise to support and guide their portfolio companies through critical growth stages.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
Recorded Recipients2
Closed Recipients1
Public Recipients1
Top Investment Stages
Series A1 (100.0%)
Stage Mix
Series A 100%
Concentration shown as share of recorded participations by stage.
